GMR Solutions Inc. GMRS
11.40 USD -0.36 (-3.06%)
Nov 12, 2026, 9:45 AM EST
11.43 Day range 11.73
9.00 52-week range 15.98
- YTD
- -18.45%
- 1 year
- -18.45%
News
benzinga.com Citigroup Maintains Buy on GMR Solutions, Lowers Price Target to $15 Citigroup analyst Joanne Wuensch maintains GMR Solutions (NYSE:GMRS) with a Buy and lowers the price target from $17 to $15.
marketbeat.com What GMR Solutions (GMRS) Said on Its Q3 Earnings Call GMR Solutions NYSE: GMRS reported higher third-quarter revenue and earnings as demand for emergency medical services grew, but lowered the top end of its full-year revenue outlook amid unfavorable…
seekingalpha.com GMR Solutions Inc. (GMRS) Q3 2026 Earnings Call Transcript GMR Solutions Inc. ( GMRS ) Q3 2026 Earnings Call November 10, 2026 8:00 AM EST Company Participants Krister Sorensen - Vice President of Investor Relations Nicola Loporcaro - CEO & Chairman of the…
benzinga.com GMR Solutions Q3 2026 Earnings Call Transcript GMR Solutions (NYSE:GMRS) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…
zacks.com GMR Solutions Inc. (GMRS) Reports Q3 Earnings: What Key Metrics Have to Say The headline numbers for GMR Solutions Inc. (GMRS) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall…
benzinga.com GMR Solutions Narrows FY2026 Sales Guidance from $5.890B-$6.180B to $5.900B-$6.050B vs $6.034B Est GMR Solutions (NYSE:GMRS) narrows FY2026 sales outlook from $5.890 billion-$6.180 billion to $5.900 billion-$6.050 billion vs $6.034 billion estimate.
benzinga.com GMR Solutions Q3 Adj. EPS $0.64 Beats $0.51 Estimate, Sales $1.595B Beat $1.589B Estimate GMR Solutions (NYSE:GMRS) reported quarterly earnings of $0.64 per share which beat the analyst consensus estimate of $0.51 by 25.49 percent. The company reported quarterly sales of $1.595 billion…
businesswire.com GMR Solutions Inc. Reports Financial Results for the Three and Nine Months Ended September 30, 2026 and Updated Full Year 2026 Guidance LEWISVILLE, Texas--(BUSINESS WIRE)--GMR Solutions Inc. Reports Financial Results for the Three and Nine Months Ended September 30, 2026 and Updated Full Year 2026 Guidance.
benzinga.com Bell Textron Receives Order From Global Medical Response For Additional Bell 407GXis To Expand All-Weather Air Ambulance Fleet These IFR-equipped aircraft will support reliable, all-weather air medical operationsAMTC 2026 – Bell Textron Inc., a Textron Inc. (NYSE:TXT) company, announced today during the annual Air Medical…
benzinga.com GMR Solutions Q2 2026 Earnings Call Transcript GMR Solutions (NYSE:GMRS) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to…- benzinga.com GMR Solutions Announces $200M Debt Repayment And Term Loan Repricing, Expects To Save $28M Annually GMR Solutions Inc. ("GMR") (NYSE:GMRS), the nation’s largest provider of emergency medical services, announced that Global Medical Response, Inc., the borrower under its first lien term loan, has…
benzinga.com JP Morgan Maintains Overweight on GMR Solutions, Raises Price Target to $16 JP Morgan analyst Benjamin Rossi maintains GMR Solutions (NYSE:GMRS) with a Overweight and raises the price target from $15 to $16.- benzinga.com GMR Solutions Affirms FY2026 Sales Guidance of $5.890B-$6.180B vs $6.018B Est GMR Solutions (NYSE:GMRS) affirms FY2026 sales outlook from $5.890 billion-$6.180 billion to $5.890 billion-$6.180 billion vs $6.018 billion estimate.
- benzinga.com GMR Solutions Q2 EPS $(1.84) Misses $(0.16) Estimate, Sales $1.490B Beat $1.469B Estimate GMR Solutions (NYSE:GMRS) reported quarterly losses of $(1.84) per share which missed the analyst consensus estimate of $(0.16) by 1050 percent. This is a 781.48 percent decrease over earnings of…
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Niki BioSolutions (NASDAQ:NIKI) stock moved upwards by 44.7% to $13.01 during Thursday's pre-market session. The company's market cap stands at $73.2 million. Zhengye Biotechnology…- benzinga.com Evercore ISI Group Initiates Coverage On GMR Solutions with Outperform Rating, Announces Price Target of $20 Evercore ISI Group analyst Elizabeth Anderson initiates coverage on GMR Solutions (NYSE:GMRS) with a Outperform rating and announces Price Target of $20.
- benzinga.com Morgan Stanley Initiates Coverage On GMR Solutions with Equal-Weight Rating, Announces Price Target of $14 Morgan Stanley analyst Craig Hettenbach initiates coverage on GMR Solutions (NYSE:GMRS) with a Equal-Weight rating and announces Price Target of $14.
benzinga.com Goldman Sachs Initiates Coverage On GMR Solutions with Buy Rating, Announces Price Target of $35 Goldman Sachs analyst Scott Fidel initiates coverage on GMR Solutions (NYSE:GMRS) with a Buy rating and announces Price Target of $35.- benzinga.com B of A Securities Initiates Coverage On GMR Solutions with Buy Rating, Announces Price Target of $18 B of A Securities analyst Joanna Gajuk initiates coverage on GMR Solutions (NYSE:GMRS) with a Buy rating and announces Price Target of $18.
benzinga.com UBS Initiates Coverage On GMR Solutions with Buy Rating, Announces Price Target of $20 UBS analyst A.J. Rice initiates coverage on GMR Solutions (NYSE:GMRS) with a Buy rating and announces Price Target of $20.- benzinga.com Citigroup Initiates Coverage On GMR Solutions with Buy Rating, Announces Price Target of $17 Citigroup analyst Daniel Grosslight initiates coverage on GMR Solutions (NYSE:GMRS) with a Buy rating and announces Price Target of $17.
- benzinga.com Barclays Initiates Coverage On GMR Solutions with Overweight Rating, Announces Price Target of $16 Barclays initiates coverage on GMR Solutions (NYSE:GMRS) with a Overweight rating and announces Price Target of $16.
- benzinga.com JP Morgan Initiates Coverage On GMR Solutions with Overweight Rating, Announces Price Target of $15 JP Morgan analyst Benjamin Rossi initiates coverage on GMR Solutions (NYSE:GMRS) with a Overweight rating and announces Price Target of $15.
- benzinga.com Full Transcript: GMR Solutions Q1 2026 Earnings Call
benzinga.com GMR Solutions Q1 EPS $0.28 Up From $(0.03) YoY, Sales $1.458B Up From $1.367B YoY GMR Solutions (NYSE:GMRS) reported quarterly earnings of $0.28 per share. This is a 1033.33 percent increase over losses of $(0.03) per share from the same period last year. The company reported…- benzinga.com GMR Solutions Notes That Credit Rating Upgrades By Moody's And S&P Will Yield Interest Expense Savings GMR Solutions Inc. (NYSE:GMRS) and its wholly owned subsidiary Global Medical Response, Inc. (collectively, "GMR") welcome recent rating actions from both Moody's Ratings and S&P Global Ratings,…